acute urinary retention. Hyperplasia of prostate
Conditions
Interventions
Intervention 1: In the intervention group, 10 mg Tadalafil tablets plus 0.4 mg Tamsulosin capsule once a day for seven days. Intervention 2: Placebo pills (in the same way, the size and color of tadal
Treatment - Drugs
Placebo
In the intervention group, 10 mg Tadalafil tablets plus 0.4 mg Tamsulosin capsule once a day for seven days
Placebo pills (in the same way, the size and color of tadalafil made from starch) with Tamsulosin capsules 0.4 milligrams per night for one week
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
45 Years to 6 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients who refused to participate in the study and signed informed consent form; Age over 50 years;Symptoms of LUTS or urinary tract symptoms.Exclusion criteria: Discontent of continued cooperation with the study for any reason and at any stage of the research; Age less than 50 years; Proven history of prostate cancer; Prostatitis; Urethral obstruction caused by tumor; known tumor disease caused by lower urinary tract (bladder stones, neurogenic bladder, bladder cancer, urethral stricture); Surgery lower urinary tract (bladder, prostate and urethra); Nitrate consumption at the same time; Acute urinary retention after surgery
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute Urinary Retention. Timepoint: 24 hours and one week after the intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZeinab Ameli
Sabzevar University of Medical Sciences
Outcome results
None listed